Covid-19 and CVD clinical resources

A collection of resources on Covid-19 and cardiovascular disease for health professionals and related information for patients.

Clinical resources

Guidance on myocarditis and pericarditis after mRNA COVID-19 Vaccines

The Australian Technical Advisory Group on Immunisation (ATAGI) and the Cardiac Society of Australia and New Zealand (CSANZ) has issued the following updated guidance on myocarditis and pericarditis after Covid 19 vaccinations. Updated November 2022.

Read the advice (PDF)

Cardiovascular disease and Covid-19: Australian and New Zealand consensus statement – April 2020

A consensus statement summarising current available data on Covid-19 and cardiovascular disease has been published in the Medical Journal of Australia.

The statement highlights issues of Covid-19 complications in cardiac patients and advises health services on ways they can minimise transmission risk while continuing to deliver cardiac care. It is a ‘living document’ and will be updated as more information becomes available.

The statement is endorsed by:

Cardiac Society of Australia and New Zealand (CSANZ)
The Heart Foundation of Australia
High Blood Pressure Research Council of Australia
Australian and New Zealand Society of Cardiac and Thoracic Surgeons

Read the consensus statement

Resources for patients

Free patient phone line

The Heart Foundation has a nurse-run free phone line for advice about heart conditions and can give information on Covid-19 and the heart.

The Heart Helpline is available on 0800 863 375 Monday to Friday 9.00am to 5.00pm.

On weekends or public holidays, patients can email hearthealthinfo@heartfoundation.org.nz.

Online Covid-19 information

We also have a number of information pages for cardiac patients about Covid-19. These will be updated in coming weeks.